USPTO trademark

AIM2 DISCOVERY CENTER

Opposition periodUSPTOFigurative markClass 42

"AIM2 DISCOVERY CENTER" is a figurative mark owned by Pfizer Inc., filed at the USPTO on April 23, 2026. It is in its opposition period and covers class 42 (Computer and Scientific Services).

Official USPTO record
AIM2 DISCOVERY CENTER trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 29, 2026
Filed
April 23, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99782654
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns AIM2 DISCOVERY CENTER

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services AIM2 DISCOVERY CENTER is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Notification of examiners amendment e-mailed
  6. Examiner's amendment entered
  7. Examiners amendment e-mailed
  8. Examiners amendment -written
  9. Notification of non-final action e-mailed
  10. Non-final action e-mailed

5 earlier steps on the official record.

FAQ

About AIM2 DISCOVERY CENTER

Who owns the trademark "AIM2 DISCOVERY CENTER"?

The USPTO trademark "AIM2 DISCOVERY CENTER" (application 99782654) is owned by Pfizer Inc.

What is the status of "AIM2 DISCOVERY CENTER"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AIM2 DISCOVERY CENTER and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019dc764-6f5a-734c-81c5-1fbc52b11fea
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019dc764-6f5a-734c-81c5-1fbc52b11fea",
  "object": "trademark",
  "mark_text": "AIM2 DISCOVERY CENTER",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99782654",
  "filing_date": "2026-04-23",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "Pfizer Inc.",
      "entity_id": "ent_019f2853-15ff-713b-878b-ed770179b310"
    }
  ]
}